These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24937535)

  • 1. The disposition index does not reflect β-cell function in IGT subjects treated with pioglitazone.
    DeFronzo RA; Tripathy D; Abdul-Ghani M; Musi N; Gastaldelli A
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3774-81. PubMed ID: 24937535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.
    Tripathy D; Clement SC; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Gastaldelli A; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD; DeFronzo RA
    Diabetes Care; 2014 Jun; 37(6):1706-11. PubMed ID: 24705615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates.
    Defronzo RA; Tripathy D; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Clement SC; Gastaldelli A; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Musi N; Reaven PD;
    Diabetes; 2013 Nov; 62(11):3920-6. PubMed ID: 23863810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.
    Tripathy D; Cobb JE; Gall W; Adam KP; George T; Schwenke DC; Banerji M; Bray GA; Buchanan TA; Clement SC; Henry RR; Kitabchi AE; Mudaliar S; Ratner RE; Stentz FB; Reaven PD; Musi N; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 2015 May; 100(5):1855-62. PubMed ID: 25603459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
    Osei K; Gaillard T; Schuster D
    Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
    DeFronzo RA; Banerji MA; Bray GA; Buchanan TA; Clement S; Henry RR; Kitabchi AE; Mudaliar S; Musi N; Ratner R; Reaven P; Schwenke DC; Stentz FD; Tripathy D;
    Diabetologia; 2010 Mar; 53(3):435-45. PubMed ID: 20012012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone on beta-cell function in metabolic syndrome patients with impaired glucose tolerance.
    Jin J; Yu Y; Yu H; Wang C; Zhang X
    Diabetes Res Clin Pract; 2006 Dec; 74(3):233-41. PubMed ID: 16764964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.
    Espinoza SE; Wang CP; Tripathy D; Clement SC; Schwenke DC; Banerji MA; Bray GA; Buchanan TA; Henry RR; Kitabchi AE; Mudaliar S; Stentz FB; Reaven PD; DeFronzo RA; Musi N
    Age (Dordr); 2016 Dec; 38(5-6):485-493. PubMed ID: 27585671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.
    Gastaldelli A; Casolaro A; Pettiti M; Nannipieri M; Ciociaro D; Frascerra S; Buzzigoli E; Baldi S; Mari A; Ferrannini E
    Clin Pharmacol Ther; 2007 Feb; 81(2):205-12. PubMed ID: 17259945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.
    Abdul-Ghani MA; Matsuda M; Jani R; Jenkinson CP; Coletta DK; Kaku K; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E401-6. PubMed ID: 18492770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
    Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
    Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial.
    Rissanen A; Howard CP; Botha J; Thuren T;
    Diabetes Obes Metab; 2012 Dec; 14(12):1088-96. PubMed ID: 22726220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones improve beta-cell function in type 2 diabetic patients.
    Gastaldelli A; Ferrannini E; Miyazaki Y; Matsuda M; Mari A; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E871-83. PubMed ID: 17106061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone prevents reactive hypoglycemia in impaired glucose tolerance.
    Arii K; Ota K; Suehiro T; Ikeda Y; Nishimura K; Kumon Y; Hashimoto K
    Diabetes Res Clin Pract; 2005 Sep; 69(3):305-8. PubMed ID: 16098929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.
    Yu X; Chen P; Wang H; Zhu T
    Med Princ Pract; 2013; 22(2):156-60. PubMed ID: 22964975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.